Cronos Group (CRON)
(Delayed Data from NSDQ)
$2.90 USD
-0.12 (-3.97%)
Updated May 17, 2024 04:00 PM ET
After-Market: $2.91 +0.01 (0.34%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Cronos Group (CRON) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$2.87 | $3.65 | $2.12 | -4.97% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Cronos Group comes to $2.87. The forecasts range from a low of $2.12 to a high of $3.65. The average price target represents a decline of 4.97% from the last closing price of $3.02.
Analyst Price Targets (7 )
Broker Rating
Cronos Group currently has an average brokerage recommendation (ABR) of 2.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.29 | 2.29 | 2.29 | 2.38 | 2.38 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/15/2024 | CIBC World Markets Corp. | John Zamparo | Strong Buy | Strong Buy |
5/9/2024 | Roth Capital Partners | William Kirk | Strong Buy | Strong Buy |
10/16/2023 | Canaccord Genuity | Matt Bottomley | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.29 |
ABR (Last week) | 2.29 |
# of Recs in ABR | 7 |
Average Target Price | $2.90 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | 0.00 |